SELECT Trial The SELECT trial, one of the largest cardiovascular outcomes trials in obesity medicine, enrolled over 17,000 participants with established cardiovascular disease and obesity or overweight (without diabetes) and demonstrated a 20% reduction in MACE with semaglutide 2.4 mg
It means the evidence base is theoretical, anecdotal, and rooted in pharmacokinetic modeling rather than clinical outcomes data
ISBN 978-1846038198
In the STEP 1 study, 15% of semaglutide patients reported headaches compared to 12% on placebo
INGREDIENTS: UNFLAVOURED - Premium Grade Acetyl-L-Carnitine (100%) LEMON Premium Grade Acetyl-L-Carnitine, Natural Lemon Flavour, Organic Stevia TROPICAL Premium Grade Acetyl-L-Carnitine, Natural Tropical Flavour, Organic Stevia WATERMELON - Premium Grade Acetyl-L-Carnitine, Natural Watermelon Flavour, Organic Stevia Product is allergen FREE, however is manufactured in a facility that produces products containing gluten